ABOUT THE EVENT
Date: Friday, September 26, 2025 8am–6:10pm PDT
Event Location: San Francisco , California
hubXchange is pleased to present the Oligonucleotides & Peptides Xchange – San Francisco 2025, a high-level, invitation-only event tailored for senior executives and scientists. This unique forum explores the most pressing scientific and strategic challenges across the therapeutic and development pipeline for oligonucleotides and peptides.
Focus Tracks
Innovation in Therapeutic Modalities
Translational & Clinical Strategy
Oligonucleotide CMC & Process Development
Peptide CMC & Process Development
🔹 Why Attend?
✅ Join thought-provoking roundtables led by leading researchers and developers
✅ Discover emerging tools, technologies, and delivery systems in nucleic acid and peptide therapeutics
✅ Network in pre-booked 1:1 meetings with key stakeholders
✅ Explore cutting-edge poster and spotlight presentations
✅ Collaborate on next-gen delivery, safety, and scalability solutions
🔹 Agenda Highlights
Key Roundtable Discussions
Massa Shoura (XAIGene Biotechnology): Circular DNA and its role in human health and disease
Janaiah Kota (Ultragenyx): Designing and delivering precision oligonucleotide therapeutics
Khiem Nguyen (Ultragenyx): Robust QC processes in oligonucleotide manufacturing
Abdulkader Rahmo (SMSbiotech): Peptide-driven mechanisms in stem cell therapies
Maria Garat (Eolo Pharmaceuticals): First-in-class molecules for creatine-dependent thermogenesis
Ishaan Chetty (Grann Pharmaceuticals): mRNA–LNP therapies for obesity and MASLD
Shengjiang Shawn Liu (Avirmax): Peptide-enhanced AAV delivery for gene therapy
Spotlight & Poster Presentations
Laura Reyes (Nostrum Biodiscovery): AI-enhanced design of therapeutic nucleic acids
Allen Shen (XAIGene): Solving design and delivery challenges in next-gen therapeutics
ChemGenes: Smart toxicology design for oligo/peptide therapeutics
Sponsored Roundtables
ChemGenes (Oligonucleotide CMC)
YMC America (Peptide CMC)
